SCM
ELGX

Suffolk Capital Management’s Endologix Inc ELGX Stock Holding History

Suffolk Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-18,083
Closed -$3.15M – 162
2013
Q4 		$3.15M Buy
18,083
+1,580
+10% +$271K 0.39% 70
2013
Q3 		$2.66M Sell
16,503
-500
-3% -$78.7K 0.36% 97
2013
Q2 		$2.26M Buy
+17,003
New +$2.4M 0.33% 110

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Suffolk Capital Management's ELGX Position: Q1 2014 in Review

Suffolk Capital Management sold out of Endologix Inc (ELGX) in Q1 2014, closing a stake of 18,083 shares — an estimated $3.15M sold.

Suffolk Capital Management first reported a position in ELGX in Q2 2013 and held it in 3 quarters. The position peaked at $3.15M in Q4 2013. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2014.

  • Suffolk Capital Management reported no remaining Endologix Inc position as of Q1 2014 after selling out during the quarter.
  • Suffolk Capital Management sold 18,083 Endologix Inc shares in Q1 2014, an estimated $3.15M.
  • Suffolk Capital Management first reported a position in Endologix Inc in Q2 2013 and held it in 3 quarters.
  • Suffolk Capital Management's Endologix Inc position peaked at $3.15M in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2014.

Based on Suffolk Capital Management's 13F filing for Q1 2014, filed 8 May 2014.